FDA Inspection 1002815 — Qiagen GmbH
The FDA completed an inspection of Qiagen GmbH on Feb 9, 2017 in Hilden. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 9, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Project Evaluation: Devices
- Location
- Hilden (Germany)
Additional details
Postmarket Audit Inspections